Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
An Enquiry
Product Reset all filters
01 1Winrevair
Sotatercept
Merck & Co.
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2024 Revenue in Millions : 419
2023 Revenue in Millions : 0
Growth (%) : NA
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF